Table 3.
Reasons of Termination during the 12-Week Treatment Phase
| Reasons for Termination During Acute Phase |
Remission Group (n = 208 [22.5%]) |
Non-Remission Group (n = 194 [33.5%]) |
P-value |
|---|---|---|---|
| Patient withdrew | 1 (0.5%) | 4 (2.1%) | 0.15 |
| Patient lost to follow-up | 4 (1.9%) | 7 (3.6%) | .30 |
| Side Effect | 13 (6.3%) | 16 (8.3%) | .44 |
| Withdraw by study physician | 5 (2.4%) | 14 (7.2%) | <.02 |
| Noncompliance | 19 (9.1%) | 13 (6.7%) | <.37 |
| Death | 3 (1.44%) | 5 (2.58%) | 0.42 |
| Other | 2 (0.9%) | 6 (3.1%) | .13 |